Why the study?
Earlier hypertrophic cardiomyopathy guidelines required updates based on new evidence or a better understanding of earlier evidence to guide diagnosis and management in adult and pediatric patients.
Provides the 2020 AHA/ACC clinical practice guideline recommendations for the diagnosis and treatment of hypertrophic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Offers practical distillation of 2020 AHA/ACC HCM guidelines; extends prior recommendations while leaving implementation outcomes open.
Ommen et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: